Targeted deep next generation sequencing identifies potential somatic and germline variants for predisposition to familial Burkitt lymphoma
Eur J Haematol
.
2021 Jul;107(1):166-169.
doi: 10.1111/ejh.13629.
Epub 2021 Apr 12.
Authors
Motohito Okabe
1
,
Takanobu Morishita
1
,
Takahiko Yasuda
2
,
Hirotoshi Sakaguchi
3
,
Masashi Sanada
4
,
Keisuke Kataoka
5
,
Seishi Ogawa
6
,
Yuichi Shiraishi
7
,
Tomoe Ichiki
1
,
Yuka Kawaguchi
1
,
Marie Ohbiki
1
,
Rena Matsumoto
1
,
Masahide Osaki
1
,
Tatsunori Goto
1
,
Yukiyasu Ozawa
1
,
Koichi Miyamura
1
Affiliations
1
Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
2
Clinical Research Center, Nagoya Medical Center, National Hospital Organization, Nagoya, Japan.
3
Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
4
Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
5
Division of Molecular Oncology, National Cancer Center Research Institute, Tokyo, Japan.
6
Department of Pathology and Tumor biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
7
Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
PMID:
33772882
DOI:
10.1111/ejh.13629
No abstract available
Publication types
Letter
MeSH terms
Burkitt Lymphoma / diagnosis*
Burkitt Lymphoma / genetics*
Family
Genetic Association Studies*
Genetic Predisposition to Disease*
Germ-Line Mutation*
High-Throughput Nucleotide Sequencing* / methods
Humans
Mutation*